Article
Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges
2023-03-07
Abstract excerpt
<h4>Background: </h4> Lymphoproliferative disorder represents a heterogeneous clinicopathological spectrum characterized by uncontrolled proliferation of lymphocytes. Immunodeficiency is a major trigger of its development. While induction of immunodeficiency is a well-known adverse effect of temozolomide therapy, development of lymphoproliferative disorder following temozolomide therapy has not previously been des...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 448320c0-4963-555b-980c-196bf381f8ff
- DOI
- 10.21203/rs.3.rs-2563990/v1
